Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 122,302 shares at $32.07 ($3.9M) on 2024-12-09, disclosed to the SEC on 2024-12-09.
Scheduled sale ($3.9M) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.07 | 61,151 | $2.0M | 50.0% |
| 2 | $32.07 | 61,151 | $2.0M | 50.0% |
| Total | $32.07 avg | 122,302 | $3.9M | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |